FDA approval of obesity drugs: a difference in risk-benefit perceptions. | Colorado PROFILES

Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)

Menu

Contact Us
If you have any questions or feedback please contact us.

FDA approval of obesity drugs: a difference in risk-benefit perceptions.

Morrato EH, Allison DB. FDA approval of obesity drugs: a difference in risk-benefit perceptions. JAMA. 2012 Sep 19; 308(11):1097-8.

View in: PubMed

subject areas

authors with profiles

Elaine Morrato

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)